抗體市場：目標、技術、管道數據庫：1 年訂閱

作為抗體數據庫，本報告提供了超過 6,231 個與抗體療法相關的上市和研發項目的在線信息。 預定義目標和技術的向下滾動菜單使選擇感興趣的項目變得容易。

內容

表格格式的項目列表

• 藥品代碼
• 目標
• 複合類
• 公司
• 字段
• 治療領域
• 適應症
• 研發階段

治療領域

• 循環系統/血液
• 皮膚科
• 消化系統
• 泌尿科、腎科、婦科領域
• 傳染病和毒理學
• 代謝和分泌
• 神經學/精神病學
• 腫瘤學
• 眼科/耳鼻喉科
• 骨科、牙科、麻醉科、外科
• 肺/呼吸系統
• 風濕病和自身免疫性疾病

默認技術向下滾動菜單 - 示例

• 按負載分類的抗體-藥物偶聯物（例如 auristatin、PBD）
• 雙特異性抗體
• 寡聚/多克隆抗體
• 體外產生的抗體（噬菌體展示）
• Fab 抗體
• Fc-融合蛋白
• 激動劑抗體
• 轉基因小鼠抗體
• 人類細胞來源的抗體

默認目標向下滾動菜單 - 示例

• 抗體-藥物偶聯物 (ADC)
• 2022 年抗體銷售額
• 2022 年生物仿製藥抗體銷售額
• 生物仿製藥抗體
• Bio-Superior 抗體
• CLDN6 抗體
• 2抗體
• c-MET/HGF 抑製劑
• CD20 抗體
• DLL3 抗體
• GPC3 抗體
• Her2 抗體
• IGF-1R 拮抗劑
• 免疫細胞因子
• 免疫毒素
• 白細胞介素 12/23 拮抗劑
• 白介素 13 拮抗劑
• 白介素 17 拮抗劑
• 間皮素抗體
• PSMA 抗體
• ROR1 抗體

Subscription to La Merie Publishing's proprietary Antibody Database provides online access to information about more than 6,231 project entries for therapeutic antibodies on the market and in research & development. Pre-established and free search functions allow to identify antibodies according to their

• Technology (e.g. antibody-drug conjugate, bispecific, isotype, phage display)

• Target (e.g. Her2, CD20, PD-1/PD-L1, CLDN18)

• Pipelines (selected by target, therapeutic area, company, technology)

• Sales (for marketed antibodies)

• R&D Phase (clinical phases, market, preclinical)

• Territory (countrywise)

• Therapeutic Area (e.g. infectious, oncology, gastrointestinal)

• Drug Code/Name (for individual molecules)

Each project is specified for its Target, Therapeutic Area and R&D Phase. Use of the R&D database of therapeutic antibodies is intuitive. Data sets of interest can be printed and exported as reports in Excel or Word format. Projects are being updated continuously. The R&D history of each project with online references of information sources can be viewed and printed. Sales figures of major therapeutic antibodies on the market are provided. An advanced search function allows to combine search parameters. A scroll down menu for predefined targets and technologies conveniently selects projects of interest. By clicking on column heads of the project list, projects can be arranged in ascending or descending alphabetical or numerical order, e.g. for phase or company name.

Special Focus of the Database:

• Antibody-Drug Conjugates
• Bispecific Antibodies
• Vectorized Antibodies (in vivo expression)
• Masked Antibodies
• TCR-like Antibodies
• T-Cell Engaging Antibodies
• Natural Killer (NK) Cell Engaging Antibodies
• Biosimilar and Biosuperior Antibodies
• Sales Data of more than 120 therapeutic antibodies (incl. sales history)

Prerequisite: Internet access.

Purchase of the subscription provides a 1-year online access to the data of the Antibody Target, Technology & Pipeline Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase.

Benefits from the Antibody Pipeline Database:

• Intuitive use
• Designed for structured searches
• Focused on targets, therapeutic areas and R&D phases
• Ideal for competitor analysis (companies, targets, technologies, R&D phase)
• Cost-effective and rapid solution for benchmarking
• Identification of licensing candidates

Project listing in a tabular format:

• Drug Codes
• Target
• Class of Compound
• Company
• Territory
• Therapeutic Area
• Indication
• R&D Phase

Therapeutic Areas:

• Cardiovascular & blood
• Dermatology
• Gastrointestinal
• Genitourinary, renal & gynecology
• Infectious & toxicology
• Metabolism & endocrine
• Neurology & psychiatry
• Oncology
• Ophthalmology & otorhinolaryngology
• Orthopedics, dental, anesthesia & surgery
• Pulmonary & respiratory
• Rheumatoid & autoimmune

Predefined Technologies Scroll-Down Menu - examples:

• Antibody-Drug Conjugates per Payload (e.g. Auristatin, PBD)
• Bispecific Antibodies
• Oligo- and Polyclonal Antibodies
• In vitro generated Antibodies (phage display)
• Fab Antibodies
• Fc-Fusion Proteins
• Agonist Antibodies
• Transgenic Mouse Antibodies (e.g. XenoMouse, VelocImmune Mouse, KM Mouse)
• Human Cell-Derived Antibodies

Predefined Targets of the Scroll Down Menu - examples:

• Antibody-Drug Conjugates (ADC)
• Antibody Sales in 2022
• Biosimilar Antibody Sales in 2022
• Biosimilar Antibodies
• Biosuperior Antibodies
• CLDN6 Antibodies
• 2 Antibodies
• c-MET/HGF Inhibitors
• CD20 Antibodies
• DLL3 Antibodies
• GPC3 Antibodies
• Her2 Antibodies
• IGF-1R Antagonists
• Immunocytokines
• Immunotoxins
• Interleukin-12/23 Antagonists
• Interleukin-13 Antagonists
• Interleukin-17 Antagonists
• Mesothelin Antibodies
• PSMA Antibodies
• ROR1 Antibodies